Your browser doesn't support javascript.
loading
A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans.
Lindestam Arlehamn, Cecilia S; McKinney, Denise M; Carpenter, Chelsea; Paul, Sinu; Rozot, Virginie; Makgotlho, Edward; Gregg, Yolande; van Rooyen, Michele; Ernst, Joel D; Hatherill, Mark; Hanekom, Willem A; Peters, Bjoern; Scriba, Thomas J; Sette, Alessandro.
Afiliação
  • Lindestam Arlehamn CS; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America.
  • McKinney DM; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America.
  • Carpenter C; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America.
  • Paul S; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America.
  • Rozot V; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Makgotlho E; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Gregg Y; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • van Rooyen M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Ernst JD; Department of Medicine, Division of Infectious Diseases, New York University School of Medicine, New York, New York, United States of America.
  • Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Hanekom WA; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Peters B; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America.
  • Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Sette A; La Jolla Institute for Allergy and Immunology, Department of Vaccine Discovery, La Jolla, California, United States of America.
PLoS Pathog ; 12(7): e1005760, 2016 07.
Article em En | MEDLINE | ID: mdl-27409590
ABSTRACT
We performed a quantitative analysis of the HLA restriction, antigen and epitope specificity of human pathogen specific responses in healthy individuals infected with M. tuberculosis (Mtb), in a South African cohort as a test case. The results estimate the breadth of T cell responses for the first time in the context of an infection and human population setting. We determined the epitope repertoire of eleven representative Mtb antigens and a large panel of previously defined Mtb epitopes. We estimated that our analytic methods detected 50-75% of the total response in a cohort of 63 individuals. As expected, responses were highly heterogeneous, with responses to a total of 125 epitopes detected. The 66 top epitopes provided 80% coverage of the responses identified in our study. Using a panel of 48 HLA class II-transfected antigen-presenting cells, we determined HLA class II restrictions for 278 epitope/donor recognition events (36% of the total). The majority of epitopes were restricted by multiple HLA alleles, and 380 different epitope/HLA combinations comprised less than 30% of the estimated Mtb-specific response. Our results underline the complexity of human T cell responses at a population level. Efforts to capture and characterize this broad and highly HLA promiscuous Mtb-specific T cell epitope repertoire will require significant peptide multiplexing efforts. We show that a comprehensive "megapool" of Mtb peptides captured a large fraction of the Mtb-specific T cells and can be used to characterize this response.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Linfócitos T CD4-Positivos / Epitopos de Linfócito T / Antígenos de Bactérias Limite: Adult / Female / Humans / Male País como assunto: Africa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Linfócitos T CD4-Positivos / Epitopos de Linfócito T / Antígenos de Bactérias Limite: Adult / Female / Humans / Male País como assunto: Africa Idioma: En Ano de publicação: 2016 Tipo de documento: Article